Image

Different Modalities Interventions Post Supracondylar Humeral Fracture in Pediatrics

Different Modalities Interventions Post Supracondylar Humeral Fracture in Pediatrics

Recruiting
6-10 years
All
Phase N/A

Powered by AI

Overview

the aim of the study is comparing the effects of LLLT and PEMFT on range of motion of elbow and radioulnar joint ,pain ,muscles strength of upper limb and hand function in children with post-operative type II and III supracondylar humeral fracture.

Description

intervention study describe the effects of low level laser and pulsed electromagnetic field in children with supracondylar humeral fracture . All children will be randomly classified by envelope method into two study groups of equal number. study group A and study group B. Both groups will receive designed physical therapy program, 20 minutes, 3 times per week for six weeks in addition to study group A will receive LLLT, 5 minutes and study group B will receive the same physical therapy program, in addition to PEMF, 20 minutes.

Eligibility

Inclusion Criteria:

  1. Age ranges from 6 to 10 years of both genders.
  2. All subjects have unilateral extension type II and III supracondylar humeral fracture requiring closed reduction and percutaneous pinning (CRPP).
  3. The study will be start immediately after removal the splint.
  4. Children clinically and medically stable.
  5. Children able to follow verbal commands.
  6. Children sample will represent those children who enrolled in schools and other not yet.

    -

Exclusion Criteria:

The patients will be excluded if they have one of the following criteria;

  1. Previous soft tissue injury at the same affected side of fracture.
  2. Presence of associated fractures on the ipsilateral or contralateral upper limb.
  3. Active infection near the fracture site.
  4. Children with congenital or acquired skeletal deformities in the upper limbs.
  5. Children with neurological deficits such as convulsions, involuntary movements, receiving muscle relaxants.

    -

Study details
    Supracondylar Humeral Fracture in Pediatric

NCT06220812

Cairo University

29 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.